Thus far, the membrane protein CD36 has been best justified as a transporter of fatty acids [45], and a western blot assay also suggested that CD36 expression was upregulated in metastatic CRC liver tissues from NAFLD mice, making CD36 a rational target (Fig. S7A). Here, CD36 is linked to metabolic dysfunction-associated steatotic liver disease.